blank
blank

State of the Art 2026 RD Report: Poland

1:1
This 2026 country report outlines the policy, research, care and support landscape for rare diseases in Poland.

This report gives an overview of rare disease activities in Poland in 2026, including the national action plan, research and funding, registration and biobanking, organisation of care, newborn screening, diagnostics, patient organisations, information resources, training and orphan medicinal products.

Acces this publication
blank

publication

State-of-the-Art RD Country Reports 2025 - Cover

You might also be interested in

NMG workshop 2026

ERDERA National Mirror Groups workshop: Creating, evolving and utilising national registries to advance rare disease research

Held in Riga on 9–10 June, the workshop brought National Mirror Group experts, researchers, clinicians and policymakers together to exchange practical lessons on how national rare disease registries can better support research and alignment across countries.
2

ERDERA launches Clinical Trial Call 2026 to advance early‑phase clinical trials for rare diseases

ERDERA (the European Rare Diseases Research Alliance) has opened its Clinical Trial Call to support multinational early-phase clinical trials in rare diseases. The call will fund studies designed to generate robust clinical evidence, strengthen regulatory readiness and make rare disease trials more feasible across countries.
ERDERA CTC 2026

ERDERA Clinical Trial Call – Call Text

Call text draft setting out rules, eligibility and staged application process for the ERDERA Clinical Trial Call 2026.
Erdera_IBG_2026_Poster_Social_Media

European Network Conference on Chromatinopathies (EU-CHROMNet)

November 25 - November 27

ERDERA's

search form